Collectively, these antioxidants alleviate renal anemia by reducing premature erythrocyte death, prolonging erythrocyte lifespan in circulation, and addressing the oxidative stress imbalance inherent to CKD, making them promising adjuvant therapeutic agents alongside conventional EPO or iron supplementation. The gene discussed is EPO; the disease is chronic kidney disease.